Skip to main content
Clinical Trials/IRCT201401041162N22
IRCT201401041162N22CompletedPhase 2

Effect of oral zinc on hyperbilirubinemia on LBW premature neonates admitted in NIC

Mashhad University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
2 days to 28 days (—)
Sex
All

Inclusion Criteria

  • Inclusion Criteria: Babies who admitted to NICU of Imam Reza Hospital; birth weight 1500-2500 gm;

Exclusion Criteria

  • jaundice in day one; hemolysis with positive comb’s test; severely ill babies; infection and sepsis based on clinical and lab test; those with ventilator support; five minutes apgar less than 7; congenital anomalies; intolerance of feeding ; intolerance of zinc supplementation ( gastrointestinal hemorrhage and residue, suddenly getting poor general condition) ; and mothers with sing of high or low level of serum zinc

Investigators

Similar Trials